Neurocrine Biosciences, Inc.’s NBIX share price has dipped by 18.53%, which has investors questioning if this is right time ...

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

New Delhi: Pharmaceutical major Dr Reddy's has got approval from the Subject Expert Committee (SEC) functional under the ...

Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...

BatchMaster Software is proud to welcome Erawat Pharma, one of central India's most prestigious pharmaceutical manufacturers, ...

The 13th International Pharmacy and Medicine Conference (ICPM 2025) revealed the establishment of three new pharmaceutical ...

Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...

These facilities will specialise in producing respiratory products, eye drops, antibiotic capsules, stomach medications, and ...

Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...

The Trump Administration's 10% tariff on all Chinese imports took effect on Feb. 4. Many unknowns remain, but Americans will ...

as well as other pharmaceutical products used for internal consumption, such as tablets and capsules, as well as those used for external applications, like ointments. 1 In 2024 alone, the ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in patients with Alzheimer disease, with Everolimus receiving approval for ...